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Background: We aimed to compare patient-controlled thoracic or lumbar epidural analgesia methods after
thoracotomy operations.
Methods: One hundred and twenty patients were prospectively randomized to receive either thoracic
epidural analgesia (TEA group) or lumbar epidural analgesia (LEA group). In both groups, epidural catheters were
administered. Hemodynamic measurements, visual analog scale scores at rest (VAS-R) and after coughing (VAS-C),
analgesic consumption, and side effects were compared at 0, 2, 4, 8, 16, and 24 hours postoperatively.
Results: The VAS-R and VAS-C values were lower in the TEA group in comparison to the LEA group at 2, 4, 8, and
16 hours after surgery (for VAS-R, P = 0.001, P = 0.01, P = 0.008, and P = 0.029, respectively; and for VAS-C, P = 0.035,
P = 0.023, P = 0.002, and P = 0.037, respectively). Total 24-hour analgesic consumption was different between groups
(175 +/- 20 mL versus 185 +/- 31 mL; P = 0.034). The comparison of postoperative complications revealed that the
incidence of hypotension (21/57, 36.8% versus 8/63, 12.7%; P = 0.002), bradycardia (9/57, 15.8% versus 2/63, 3.2%;
P = 0.017), atelectasis (1/57, 1.8% versus 7/63, 11.1%; P = 0.04), and the need for intensive care unit (ICU) treatment
(0/57, 0% versus 5/63, 7.9%; P = 0.03) were lower in the TEA group in comparison to the LEA group.
Conclusions: TEA has beneficial hemostatic effects in comparison to LEA after thoracotomies along with more
satisfactory pain relief profile.
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The traumatic process of a thoracotomy operation in-
volves cutting of the muscles, separation of the ribs
along with the use of retractors during the procedure,
and acute pain is expected to occur after surgery due to
damage to the intercostal nerves. For postoperative pain
management, either lumbar or thoracic epidural analgesia
is required to diminish the incidence rate of possible pul-
monary and cardiac complications [1,2]. However, the use
of nerve blocks do not provide sufficient analgesia, and
there is a need for additional analgesics to prevent break
through pain [3,4].* Correspondence: gonulsagiroglu45@gmail.com
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unless otherwise stated.The lumbar epidural analgesia (LEA) method is an al-
ternative method for thoracic epidural analgesia (TEA)
for the treatment of post-thoracotomy pain [1,5,6]. The
use of the TEA method was reported as a superior
method in comparison to LEA due to better pain control
and diminished incidence of postoperative complications
[2-4,7]. TEA reduces cardiac and splanchnic sympathetic
activity and thereby influences perioperative function of
vital organ systems. A recent meta-analysis suggested
that TEA decreased postoperative cardiac morbidity and
mortality. TEA appears to ameliorate gut injury in major
surgery as long as the systemic hemodynamic effects of
TEA are adequately controlled. The risk of harm by
TEA is even lower, and other methods used to control
perioperative pain and stress response also carry specific
risks [8].ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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gesic effects of patient-controlled thoracic or lumbar epi-
dural analgesia methods in a prospective randomized study
design after thoracotomy operations.
Methods
Institutional Review Board of Sureyyapasa Chest Disease
and Thoracic Surgery Hospital, clearance and written in-
formed patient consent were obtained. One hundred
and twenty adult patients with a diagnosis of lung cancer
underwent a posterolateral thoracotomy procedure by
one surgeon. Most incisions were performed with pos-
terolateral thoracotomy because of an advanced stage of
lung cancer and a huge mass. Muscle-sparing thoracot-
omy was applied when possible. Patients in an age range
of 46 to 86 years and of American Society of Anesthesi-
ologists (ASA) physical status I, II or III were included
in a prospective, randomized, double-blind controlled
study. The allocation of patients into groups was per-
formed according to a random numbers list. PatientsFigure 1 Consort 2010 flow diagram.were randomized to either the thoracic epidural (TEA,
n = 57) group or lumbar epidural (LEA, n = 63) group for a
24-hour postoperative period after surgery. From 147 pa-
tients, 13 were excluded as 7 of them did not meet the in-
clusion criteria and 6 of them declined to participate. A
total of 134 patients were randomized into two groups.
Two patients did not receive allocated intervention, and
intervention was discontinued in 12 patients. The Consort
diagram is presented in Figure 1. Exclusion criteria include:
1) ASA physical status > III; 2) known drug allergies; 3)
prior lumbar spine surgery; 4) pregnancy; 5) abnormal co-
agulation tests such as platelet count < 80.000, prothrom-
bin time > 1.5 min, or partial thromboplastin time > 45 s;
6) history of comorbidities such as clinical and laboratory
findings of hepatic or renal disease, valvular heart disfunc-
tion, or chronic obstructive lung disease; or 7) neurological
impairment causing inability to understand consent form
or pain measurement.
Demographic data, age, height, weight, body mass index
(BMI), cigarette smoking, pulmonary function parameters,
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ation of operation were recorded. Preoperative pulmonary
functions measured included forced expiratory volume in
one second (FEV1) and forced vital capacity (FVC). FEV1
(% predicted) and FVC (% predicted) values were deter-
mined. In addition, preoperatively, intraoperatively, and
at 2, 12 and 24 hours after surgery, arterial blood gas
values including pH, PaO2 (arterial partial pressure of
oxygen) and PCO2 (arterial partial pressure of carbon di-
oxide) were collected. Also, the Charlson comorbidity
index was used in this study, and it is classified into four
groups to define and grade any existence of comorbidities.
There are nineteen conditions that are related to increased
risk for mortality and a weighted score of 1 to 6 was
provided depending on the relative mortality risk.
All patients were premedicated with oral diazepam 0.1
mg/kg on the night before surgery. A five-lead electrocar-
diography along with an ST segment analysis provided
continuous heart rate (HR) monitoring. An ST segment
increase or decrease of ≥ 0.2 mV in men or ≥ 0.15 mV in
women was monitored to determine signs of myocardial
ischemia.
The epidural catheters were applied at the operating
table prior to the induction of anesthesia. An analgesic
solution that contains 0.125% bupivacaine with sufentanyl
(Sufentanil, Janssen Pharmaceutical, Belgium) (0.6 μg/mL)
was prepared by an anesthesia technician. All epidural
punctures were inserted with an 18 gauge Touhy needle
(B-Braun Medical, Abbott, Turkey) through T4-6 or L2-3
interspaces while patients were in a sitting position. The
epidural space was identified by using the loss of resist-
ance to saline technique, which is required to demonstrate
a negative aspiration of cerebrospinal fluid and blood.
Afterwards, a test dose of 20 mg of 2% lidocaine (Jetmonal
2%, Adeka Pharmaceutical, Turkey) with epinephrine (1:
200,000) was administered. The epidural catheter (Portex
Epidural Minipack; Smiths Medical ASD Inc, Keene, NH,
USA) was advanced in a cephalad direction and 5 mL was
administered to both groups from the epidural catheter
before general anesthesia was administered from the solu-
tion prepared before catheterization. A basal infusion at
a dose of 2 mL/h was started intraoperatively after the
anesthesia induction and just before surgery. At the
end of the surgery, a patient-controlled epidural anal-
gesia device (PCEA, Abbott Pain Management Provider,
North Chicago, IL, USA) was connected to the epidural
catheter. The infusion rate of PCEA was 0.1 mL/kg/h,
with 2 mL on demand, and a lock-out interval of 30 min
in the 24 hours postoperative period.
General anesthesia was induced with 1 μg/kg of fentanyl
(Janssen fentanyl, Janssen Pharmaceutical, Belgium) and 5
mg/kg of thiopental (Pental, IE Ulugay Pharmaceutical,
Turkey) intravenously. Tracheal intubation was facilitated
with 0.15 mg/kg vecuronium (Blok-L, Mustafa NevzatPharmaceutical, Turkey), and repeated intraoperatively if
necessary. Anesthesia was maintained with desflurane
(Suprane, Baxter, Pharmaceutical, Puerto Rico, USA) in
70% oxygen and 30% air. The oxygen concentration was
adjusted according to arterial blood gas values of partial
arterial oxygen concentration value (PaO2). A left-sided
double-lumen endobronchial tube was inserted. Correct
tube position was confirmed with the help of a stetho-
scope and confirmed by flexible fiberoptic bronchoscopy
in both the supine and lateral decubitus positions. For in-
traoperative monitoring, when mean arterial blood pres-
sure (MAP) or HR was 25% higher than the baseline
value, it was treated with 0.3 μg/kg of fentanyl. On com-
pletion of surgery, the patients were reversed with intra-
venous neostigmine and atropine at a dose of 0.04 mg/kg
and 0.02 mg/kg, respectively.
During the first 24-hour period in the intensive care
unit (ICU), MAP, HR and SpO2 values were recorded at
0, 2, 4, 8, 16, and 24 hours. First hemodynamic measure-
ments in the ICU were recorded as 0 hour values. At
any time point, an episode of hypotension was defined
as a fall in MAP more than 25% of baseline value for a
period of less than 15 minutes. Severe hypotension was
a fall in MAP more than 25% of baseline value for a
period more than 30 minutes. Both of these conditions
were treated with Ringer lactate crystalloid fluid infu-
sions. If infusion of crystalloid solution did not raise
the blood pressure, a 10 mg ephedrine (Ephedrine, Osel
Pharmaceutical, Turkey) bolus was administered and
repeated if necessary. Bradycardia was defined as heart
rate below 50 beats/min and was treated with bolus doses
of 0.4 mg atropine sulfate (Atropin sulfate, Biofarma
Pharmaceutical, Turkey).
At the end of surgery, patients were weaned from me-
chanical ventilation. Reintubation was necessary in some
patients in the ICU. Criteria for weaning from mechanical
ventilation include the following: 1) PaO2 ≥ 60 mmHg,
2) FiO2 ≤ 0.40, 3) peak end expiratory pressure (PEEP) ≤ 5
cm H2O, 4) respiratory rate (RR) < 30, 5) minute ventila-
tion of < 12 L to maintain partial arterial carbondioxide
tension (PaCO2) between 35 and 45 mmHg, 6) appropri-
ate level of consciousness, 7) intact cough and gag reflex,
8) vital capacity > 10 mL/kg, and 9) minimum inspiratory
pressure < -30 cm H2O.
Postoperatively, the incidence of nausea or vomiting
was noted. Nausea greater than 2/10 (measured by the
visual analog score (VAS)) or vomiting were treated with
10 mg intravenous metoclopramide (Metpamid, Mefar
Pharmaceutical, Turkey). Pruritus was treated by intra-
venous difenhydramine (Benison, Osel Pharmaceutical,
Turkey) 10 mg. The doses were repeated if necessary.
We administered intravenous 1,000 mg paracetamol
(Perfalgan, Bristol-Myers Squibb Pharmaceutical, France)
every 8 h to all patients during the ICU treatment. At a





(n = 63) *P
Age (years) 55.37 ± 13.3 52.73 ± 13.33 0.281
Height (cm) 167.77 ± 7.87 166.4 ± 10.705 0.428
Weight (kg) 69.39 ± 12.44 7 4.24 ± 15.83 0.066
Body mass index (kg/m2) 24.6 ± 3.58 25.14 ± 4.9 0.492
Gender (F/M)
Female 7 (12.3) 9 (14.3)
0.747
Male 50 (87.7) 54 (85.7)
ASA status
I 6 (10.5) 10 (15.9) 0.39
II 40 (70.2) 36 (57.1) 0.139
III 11 (19.3) 17 (27) 0.32
Charlson comorbidity index
0 6 (10.5) 9 (14.3) 0.534
1- 2 38 (66.7) 40 (63.5) 0.716
> 2 13 (22.8) 14 (22.2) 0.939
TEA, thoracic epidural group; LEA, lumbar epidural group; ASA, American
Society of Anesthesiologists physical status.
*P < 0.05, values are mean ± standard deviation, n (%), number (percent).
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through bolus doses of epidural analgesic agent at a dose
of 0.1 mL/kg in addition to PCA. Additional pain relief
was provided with intravenous morphine at a dose of 2
mg (Morphine HCL, Galen Pharmaceutical, Turkey) in
both groups for a VAS score > 3 at rest despite four con-
secutive PCA boluses.
After extubation, patients were assessed by a physician
in ICU to evaluate their pain at a scale from 0 (no pain)
to 10 (disabling pain) by the use of VAS. Postoperative
pain scores at rest (VAS-R) and after a strong cough
(VAS-C) were evaluated. Sedation scores were judged by
the observer (0 = awake; 1 =mild sedation; 2 =moderate
sedation, easily rousable; 3 = heavily sedated, difficult to
rouse; and 4 = over-sedated, unarousable). In each case,
pain and sedation scores were evaluated at 0, 2, 4, 8, 16,
and 24 h by a blinded resident to the study protocol on
call in the ICU.
Excessive sedation was defined as a score higher than
3 or 4 and either respiratory depression (defined as a
ventilatory frequency below 8 breaths/min) or hypercar-
bia (PaCO2 > 50 mmHg) treated with 100% oxygen sup-
plementation via a face mask. Patients were discharged
from the ICU when the following criteria were met:
SpO2 ≥ 90% at FiO2 ≤ 0.5 by face mask; hemodynamic
parameters including MAP, HR and RR within normal
adult limits; chest tube drainage < 50 mL/h; urine out-
put > 0.5 mL/kg/h; and no intravenous inotropic or vaso-
pressor therapy.
Primary and secondary study endpoints
The TEA and LEA groups were compared in the first
24-hour ICU stay for 1) hemodynamic data including
MAP, HR and arterial oxygen saturation (SaO2) values
that were recorded at 0, 2, 4, 8, 16, and 24 hours; 2) vis-
ual analog scale (VAS) score at rest (VAS-R) and after
coughing (VAS-C); 3) sedation scores; 4) the total amount
of analgesic (PCEA) and morphine consumption; 5) the
determination of postoperative complications (respiratory
failure, atelectasis, reintubation, postoperative bleeding,
bronchopleural fistula, rethoracotomy, in-hospital stay
and 30-day mortality); and 6) the record of analgesic- and
morphine-related side effects such as nausea and vomit-
ing, pruritus, sedation or other adverse events.
Statistical analysis
The Statistics Package for Social Sciences (SPSS 16.0;
SPSS Inc., Chicago, USA) was used for all calculations.
During sample size evaluation, the aim was to detect a
clinically relevant reduction in the VAS score by 30 mm.
To be able to detect a difference of 20 cm/h in the area
under the curve of the VAS score after coughing with an
expected standard deviation of 50 cm/h, and α and β er-
rors of 0.05 (two-sided hypothesis) at a power of 0.8, thecalculated sample size was 60 patients. To compensate
for unforeseen dropouts and a possibly higher variability
than expected, we planned to study 80 patients. The com-
pliance of the data of the continuous measurements to a
normal distribution was examined by the Kolmogorov-
Smirnov test. Group differences for categorical variables
were examined by Chi-square or Fisher’s exact test, as ap-
propriate. Whereas in cases of normal distribution, group
differences for continuous data were examined by inde-
pendent samples t-test, for non-normally distributed data
a Mann Whitney U-test was applied. Mann-Whitney U-
tests were used to compare nonparametric variables be-
tween independent study groups and the Wilcoxon test
for comparison between dependent groups. The difference
in the time courses of parameters between groups was
analyzed by two-way analysis of variance (ANOVA) for
repeated measures. Results are expressed as mean ± stand-
ard deviation (SD) where appropriate. For all tests, P <
0.05 was considered significant.
Results
The comparison of the baseline characteristics between
groups showed no significant difference (Table 1). The
distribution of the histologic type of cancer including
squamous cell carcinoma, adenocarcinoma and undiffer-
entiated large cell cancer were not different between the
TEA group (n (%)): 33(58), 19(33.9), and 5(8.8), respect-
ively, and the LEA group: 41(65), 16(25.4) and 6(9.5), re-
spectively. The distribution of surgical procedures were
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(18), and 5(8.8), respectively, and the LEA group, 37(59),
17(27), and 9(14.3), respectively. The surgical procedure
was a right-sided thoracotomy in most of the cases: in the
TEA group (n (%)), 45(78.9) versus in the LEA group, 42
(66.7). Also, preoperative spirometric data including FEV1
(79.56 ± 13.92 versus 83.02 ± 13.75) and FVC (81.58 ±
16.86 versus 84.92 ± 15.33) values were not different be-
tween the TEA and LEA groups.
Comparisons of arterial blood gas values of PaO2 and
PCO2, serum CK-MB and troponin values preoperatively,
and postoperatively at 6 and 24 hours, did not show statis-
tically significant differences between groups (Table 2).
The observers were blinded to the epidural analgesia
protocol. Caregivers were not blinded, but they did not
participate in data collection or data interpretation.
The postoperative hemodynamic data for MAP, HR,
RR, and SpO2 were not significantly different at any time
interval between the TEA and LEA groups. Two patients
(n/63, %) (2/63, 3.2%) in the LEA group had ST segment
depression during and after surgery. In contrast, none of
the patients in the TEA group had signs of myocardial
ischemia during or after surgery. Another patient in the
LEA group developed a severe depression in the ST seg-
ment (-0.2 mV) six hours after operation in the ICU. A
comparison of creatinine kinase MB fraction (CK-MB)
and troponin values at different time points is shown in
Table 2.
A comparison of VAS-R and VAS-C scores is pre-
sented in Tables 3 and 4. Between-group comparisons
revealed that VAS-R and VAS-C values were lower in
the TEA group in comparison to the LEA group at 2, 4, 8,
and 16 hours after surgery (for VAS-R, P = 0.001, P = 0.01,
P = 0.008, and P = 0.037 and for VAS-C, P = 0.035, P =Table 2 The comparison of PaO2, PaCO2, serum CK-MB and tr
and 24 hour between groups
Preoperative *P Postoperativ
PaO2 (mmHg)
TEA 126.54 ± 33.75
0.252
146.88 ±
LEA 135.86 ± 51.89 134.67 ±
PaCO2 (mmHg)
TEA 41.86 ± 8.28
0.152
41.32 ±
LEA 39.46 ± 9.78 43.84 ±
CK-MB (U/L)
TEA 18.5 (13-55) 0.623 22.5 (12
LEA 20 (12-25) 16 (11
Troponin (ng/mL)
TEA 0.02 (0.01-0.6) 0.758 0.3 (0.08
LEA 0.04 (0.01-0.25) 0.25 (0.09
TEA, thoracic epidural group; LEA, lumbar epidural group; PaO2, arterial partial press
values are mean ± standard deviation or median (minimum-maximum).0.023, P = 0.002, and P = 0.029; respectively). However, at
0 and 24-hour time points, the observed differences were
not statistically significant.
The comparisons within groups for VAS-R scores re-
vealed that the scores at 0 hours (5.43 ± 1.8) in the TEA
group were higher than the VAS-R scores at 2 hours
(4.28 ± 1.59; P < 0.0001), 4 hours (3.84 ± 1.84; P < 0.0001),
8 hours (1.86 ± 1.97; P < 0.0001), 16 hours (1.72 ± 1.81;
P < 0.0001), and 24 hours (1.51 ± 1.72; P < 0.0001) for
the same group. VAS-R scores at 0 hours (5.36 ± 1.85) in
the LEA group were higher than VAS-R scores at 2 hours
(5.33 ± 1.88; P = 0.038), 4 hours (4.84 ± 2.3; P < 0.0001),
8 hours (2.84 ± 2.02; P < 0.0001), 16 hours (2.49 ± 2.17;
P < 0.0001), and 24 hours (1.6 ± 1.77; P < 0.0001) of the
same group.
Within group comparisons revealed that the VAS-C
scores at 0 hours (7.75 ± 1.48) in the TEA group were
higher than the VAS-C scores at 2 hours (5.23 ± 1.96;
P < 0.0001), 4 hours (4.72 ± 2.47; P < 0.0001), 8 hours
(3.18 ± 0.66; P < 0.0001), 16 hours (3.54 ± 1.72; P < 0.0001),
and 24 hours (3.21 ± 1.7; P < 0.0001) in the same group.
VAS-C scores at 0 hours (7.32 ± 1.52) in the LEA group
were higher than VAS-C scores at 2 hours (6.02 ± 2.07;
P = 0.038), 4 hours (5.81 ± 2.7; P < 0.0001), 8 hours (4.1 ±
2.09; P < 0.0001), 16 hours (4.03 ± 1.78; P < 0.0001), and
24 hours (3.81 ± 2.01; P < 0.0001) of the same group.
While total 24-hour analgesic consumption was differ-
ent between groups (175 ± 20 mL versus 185 ± 31 mL; P =
0.034), morphine consumption was similar (8.2 ± 11.3
mg versus 10.3 ± 11 mg). There was no difference in the
use of ephedrine (19.29 ± 9.97 mg versus 12 ± 4.47 mg)
and atropine (0.61 ± 0.22 mg versus 0.5 ± 0.00) between
groups. Sedation scores were similar at 0, 2, 4, 8, 16 and
24 hours postoperatively. Two patients (3.2%) in theoponin values preoperatively and postoperatively at 6










7.7 44.89 ± 8.47
-46) 0.243 17.5 (16-35)
0.061
-26) 19.5 (23-35)
-0.75) 0.326 0.2 (0.05-0.60)
0.503
-0.55) 0.15 (0.06-0.75)
ure of oxygen; PaCO2, arterial partial pressure of carbon dioxide; *P < 0.05,
Table 3 The comparison of visual analog scale (VAS) scores at rest at different time points
Time
(hours)








TEA group (n = 57) LEA group (n = 63)
Basal 5.43 ± 1.8 5.36 ± 1.85 0.826 Δ Δ
2 4.28 ± 1.59 5.33 ± 1.88 0.001a < 0.0001b < 0.0001c
4 3.84 ± 1.84 4.84 ± 2.3 0.01a < 0.0001b < 0.0001c
8 1.86 ± 1.97 2.84 ± 2.02 0.008a < 0.0001b < 0.0001c
16 1.72 ± 1.81 2.49 ± 2.17 0.037 < 0.0001b < 0.0001c
24 1.51 ± 1.72 1.6 ± 1.77 0.768 < 0.0001b < 0.0001c
TEA, thoracic epidural group; LEA, lumbar epidural group; Values mean ± standard deviation.
aComparation between groups, P < 0.05.
bComparation to basal value in Grup TEA, P < 0.05.
cComparation to basal value in Grup LEA, P < 0.05.
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score ≥ 3 for 24 hours.
The incidence of hypotension and bradycardia and the
need for an ICU stay > 24 hours are presented in Table 5.
Severe hypotension was observed in only one patient in
each group of patients. The incidence of nausea and
vomiting of the TEA group (4/57, 7%) was lower than
the LEA group (7/63, 11.1%). Three patients with vomi-
ting received metoclopramide treatment. There was no
incidence of any other complications in both of the
groups. Urinary retention could not be assessed, since
patients routinely had Foley catheters inserted at the
time of surgery.
The duration of operation time of the TEA group was
similar to that for the LEA group (222.34 ± 74.1 min ver-
sus 204.4 ± 64.1 min). The patients in the TEA group were
discharged home in a comparable time period to the LEA
group (8.74 ± 5.62 days versus 9.17 ± 6.83 days).
Discussion
In the early postoperative period, the use of a PCEA
through either a lumber or thoracic epidural catheter
has been shown to decrease the risk of myocardial ische-
mia, improve lung ventilation and decrease incidences ofTable 4 The comparison of visual analog scale (VAS) scores a
Time
(hours)
Visual Analogue Scala-Coughing Gru
GruTEA group (n = 57) LEA group (n = 63)
Basal 7.75 ± 1.48 7.32 ± 1.52
2 5.23 ± 1.96 6.02 ± 2.07
4 4.72 ± 2.47 5.81 ± 2.7
8 3.18 ± 0.66 4.1 ± 2.09
16 3.54 ± 1.72 4.03 ± 1.78
24 3.21 ± 1.7 3.81 ± 2.01
TEA, thoracic epidural group; LEA, lumbar epidural group; Values mean ± standard d
aComparation between groups, P < 0.05.
bComparation to basal value in Grup TEA, P < 0.05.
cComparation to basal value in Grup LEA, P < 0.05.atelectasis and pneumonia [2,3,7]. In our study, a major
finding is that the incidence of hypotension and brady-
cardia were significantly lower in the TEA group in com-
parison to the LEA group. However, we have shown no
difference in the evaluation of serum CK-MB, troponin
values or ST segment analysis in a period of 24 hours
postoperatively. In a recent meta-analysis including
2,758 patients and nine studies, it was demonstrated that
TEA did not reduce perioperative myocardial ischemia
or mortality in patients undergoing noncardiac opera-
tions [9]. However, there are limited data on perioperative
outcome comparisons of patients undergoing thoracot-
omy procedure who had either a lumbar or thoracic epi-
dural for postoperative pain management. A recent study
investigated fifty-five patients with blunt chest wall trauma
who were randomized to receive an epidural morphine in-
jection once daily for 24 hours through a lumbar or thor-
acic catheter [10]. In this study, in a comparison of two
groups, no differences were found regarding incidences of
cardiac or pulmonary complications or the occurrence of
epidural morphine-related side effects. Forty patients
undergoing coronary artery bypass graft (CABG) with
normal left ventricular ejection fraction were randomized










0.035a < 0.0001b < 0.0001c
0.023a < 0.0001b < 0.0001c
0.002a < 0.0001b < 0.0001c
0.029 < 0.0001b < 0.0001c
0.082 < 0.0001b < 0.0001c
eviation.
Table 5 The comparison of analgesic related adverse






Hypotension episode 8 (12.7) 21 (36.8) 0.002*
Bradycardia 2 (3.2) 9 (15.8) 0.017*
Nausea and vomiting 7 (11.1) 4 (7) 0.438
ICU stay > 24 hr 0 (0) 5 (7.9) 0.031*
Atelectasis 1 (1.8) 7 (11.1) 0.042*
Pneumonia 2 (3.2) 3 (5.3) 0.567
Reintubation 2 (3.2) 0 0.175
Bronchopleural fistula 1 (1.6) 2 (3.5) 0.501
Rethoracotomy 2 (3.2) 3 (5.3) 0.567
Permanent neurological dysfunction 0 0 NS
*P < 0.05, (n,%), Hypotension episode: fall in systolic blood pressure more than
25% of baseline value for a period of less than 15 minutes. ICU, intensive care
unit; LEA, lumbar epidural group; TEA, thoracic epidural group; NS, not significant.
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lac tromethamine at a dose of 30 mg was administered.
In this study group, both groups had comparable car-
diac and pulmonary functions postoperatively in addition
to comparable side effects and complications [11]. In
another small randomized study, the efficacy of thor-
acic epidural sufentanil 50 micrograms was compared
with lumbar epidural sufentanil 50 micrograms in an
equally distributed group of 30 patients. Although the
number of patients who had hypotensive episodes was
higher in the TEA group, the study showed that both
techniques are comparable regarding pain relief, com-
plications and side effects [12].
Previous studies investigated the effects of TEA on left
ventricular function, and in these studies, major con-
cerns of TEA were 1) a decrease in preload related to
venodilation, 2) impairment in cardiac contractility sec-
ondary to sympathectomy at T4 dermatome level, and
3) a decrease in heart rate secondary to either sympath-
ectomy or increased vagal tone [13,14]. There is also sym-
pathetic activity during surgery and postoperative pain
that is associated with increased myocardial oxygen con-
sumption [15]. Other studies demonstrated that lumbar
epidural analgesia, when used during surgery, may cause a
major problem. This is mainly reflex arterial dilatation
and bradycardia via the Bezold-Jarisch reflex, which in-
duces events such as a reduced myocardial blood flow dis-
tal from coronary artery stenosis, a possible increase of
oxygen demand by sympathetic activation in nonblocked
thoracic segments, and an impairment of myocardial wall
motion [16]. Recently it has been suggested that, as there
is a need to restrict splanchnic sympathetic block, main-
tain venous return, and lessen hypotension, lumbar epi-
dural anesthesia should be avoided in patients undergoing
abdominal or thoracic procedures [17,18].In our study, the incidences of hypotension and brady-
cardia were significantly higher in the LEA group in
comparison to the TEA group. In a recent study, a sig-
nificantly higher incidence of hypotension with lumbar
PCEA (7.7%) was observed compared with thoracic PCEA
(4.1%) (P = 0.001) [15]. We also demonstrated that peri-
operative myocardial ischemia was not significantly differ-
ent between patients receiving either TEA or LEA, which
was shown by serum CK-MB, troponin values and ST seg-
ment analysis. In a comparison of TEA and LEA in ab-
dominal and thoracic procedures, a significant reduction
in myocardial infarction and an improvement of ischemia
induced left ventricular global and regional wall motion
abnormalities with use of TEA were demonstrated [19-21].
Also, a significantly reduced incidence of supraventricu-
lar tachycardia after both cardiac surgery and pulmonary
resection with the use of TEA was reported. However, we
were not able to demonstrate this because we used TEA
for postoperative analgesia only and not during the ope-
ration [21-23]. A previous study of the use of TEA for
postoperative analgesia after thoracotomy is not available
for a comparison of the cardioprotective effects of LEA.
The other most prominent action of TEA is on pulmon-
ary functions. TEA has been associated with earlier
mobilization, reduced opioid consumption, and improved
cough, and thus, it has beneficial effects on lung functions
causing diminished incidences of atelectasis or pneumonia
[15,24]. In another meta-analysis including only CABG,
patients reported faster extubation and less pulmonary
complications with thoracic epidural blockade [23]. In our
study, we showed that TEA causes reduced incidence of
atelectasis in comparison to LEA. No permanent neuro-
logical sequelae were reported in a total of 4,185 patients
with use of TEA; however, temporary neurological seque-
lae such as peripheral nerve injury or dural tap-related
headache are much more frequent [24].
The comparison of TEA and LEA for pain relief after
thoracotomies in the early postoperative period revealed
that both techniques provide efficient analgesia; however,
TEA has superior pain relief profile. These findings are
comparable with previous studies and meta-analyses
[2-4,11,15,19,21].
Conclusions
Although better cardioprotective effects on serum car-
diac enzymes and ST segment analysis have not been
shown, TEA has beneficial hemodynamic effects in com-
parison to LEA after thoracotomies along with a more
satisfactory pain relief profile in the 24-hour postopera-
tive period.
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